Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 60.2B | 54.9B | 55.3B | 52.3B |
Cost of revenue | 58.0B | 52.8B | 53.3B | 50.4B |
Gross profit | 2.2B | 2.1B | 1.9B | 1.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.5B | 1.3B | 1.3B | 1.3B |
Other operating expenses | — | — | — | — |
Operating income | 585M | 656M | 530M | 551M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 74M | 74M | 35M | 32M |
Other income expense | -127M | 83M | 16M | 22M |
Pretax income | 384M | 665M | 511M | 541M |
Tax provision | 141M | 157M | 110M | 124M |
Net income | 243M | 508M | 401M | 417M |
Basic EPS | 1.0 | 2.1 | 1.7 | 1.7 |
Diluted EPS | 1 | 2.1 | 1.7 | 1.7 |
Basic average shares | 239M | 240M | 242M | 243M |
Diluted average shares | 240M | 241M | 243M | 245M |
EBITDA | 824M | 872M | 719M | 738M |
Net income from continuing op. | 243M | 508M | 401M | 417M |
Minority interests | -4M | -2M | -1M | -1M |
Preferred stock dividends | — | — | — | — |